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Chorismate and isochorismate constitute branch-point inter-
mediates in the biosynthesis of many aromatic metabolites in
microorganisms and plants. To obtain unnatural compounds,
we modified the route to menaquinone in Escherichia coli. We
propose a model for the binding of isochorismate to the active
site of MenD ((1R,2S, 5S,6S)-2-succinyl-5-enolpyruvyl-6-hydroxy-
cyclohex-3-ene-1-carboxylate (SEPHCHC) synthase) that ex-
plains the outcome of the native reaction with a-ketoglutarate.
We have rationally designed variants of MenD for the conver-
sion of several isochorismate analogues. The double-variant
Asn117Arg–Leu478Thr preferentially converts (5S,6S)-5,6-dihy-
droxycyclohexa-1,3-diene-1-carboxylate (2,3-trans-CHD), the hy-
drolysis product of isochorismate, with a >70-fold higher ratio
than that for the wild type. The single-variant Arg107Ile uses
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylate
(2,3-trans-CHA) as substrate with >6-fold conversion compared
to wild-type MenD. The novel compounds have been made ac-
cessible in vivo (up to 5.3 g L1). Unexpectedly, as the identified
residues such as Arg107 are highly conserved (>94 %), some
of the designed variations can be found in wild-type SEPHCHC
synthases from other bacteria (Arg107Lys, 0.3 %). This raises
the question for the possible natural occurrence of as yet un-
explored branches of the shikimate pathway.
Chorismate is a branch-point intermediate of the shikimate
pathway, and the major precursor of aromatic metabolites in
microorganisms and plants.[1] l-Tryptophan, l-phenylalanine, l-
tyrosine, ubiquinone, folate, catechol, and salicylate are synthe-
sized from chorismate (1) and its derivatives isochorismate (2)
and aminodeoxyisochorismate (ADIC, 3).[2] Derivatives, such as
cyclohexanecarboxylate, are utilized in microorganisms for the
biosynthesis of secondary metabolites.[3, 4] The shikimate path-
way has been genetically engineered for the production of
known natural products, for example, (5S,6S)-5,6-dihydroxycy-
clohexa-1,3-diene-1-carboxylate (2,3-trans-CHD; 4) and (5S,6S)-
6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylate (2,3-trans-
CHA; 5), themselves chiral building blocks useful for stereo-
selective synthesis.[5–7] Both compounds are known from a bio-
synthetic context[8] and have been produced by microbial fer-
mentation with Escherichia coli strains (Scheme 1).[9]
In the physiological context of E. coli, chorismate (1) is
converted into isochorismate (2) by the isochorismatases EntC
and MenF. In the menaquinone (vitamin K2) biosynthesis, thia-
mine diphosphate (ThDP) dependent MenD [(1R,2S,5S,6S)-2-
succinyl-5-enolpyruvyl-6-hydroxycyclohex-3-ene-1-carboxylate
(SEPHCHC) synthase from E. coli, as used throughout this work]
catalyzes the carboligation of 2 and a-ketoglutarate (6) into
SEPHCHC (7). MenD accepts mimetics of its physiological
substrate 2, such as 4, forming (1R,2S,5S,6S)-2-succinyl-5,6-
dihydroxycyclohex-3-ene-1-carboxylate (SDHCHC) (8)
(Scheme 1).[10–12] However, further derivatives of 2, most impor-
tantly 2,3-trans-CHA (5), have been assessed as substrates with
no significant conversion by wild-type MenD.[11]
Despite this drawback, our aim was to make use of
the inherent chemical diversity of 1 and 2 and their derivatives
by rationally designed variants of MenD to enable transforma-
tion of 5. Thereby, functionalized non-aromatic cyclic com-
pounds should be accessible in vivo through metabolic
engineering, thus extending the known network of the shiki-
mate pathway to “unnatural” metabolites. Conversely, the gen-
erated compounds could act as inhibitors of the shikimate
pathway, as this pathway itself and particularly menaquinone
biosynthesis are primary targets for antibiotics against patho-
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genic strains such as Staphylococcus and Mycobacterium tuber-
culosis.
To gain (in vivo) access to SDHCHC (8), the 2,3-trans-CHD (4)
overproducer E. coli F97/pC20 was used as a host for the over-
expression of MenD. This strain had been engineered for im-
proved supply of 1.[11] After the cultivation of E. coli F97/pC20
(negative control) and E. coli F97/pC20-menD in shaking flasks,
the culture broth was analyzed by LC-MS/MS (Table S4 in the
Supporting Information). For E. coli F97/pC20-menD, a peak
corresponding to the m/z value for 8 (tR = 5.0 min, m/z 256.85)
was observed (Figure S1). Besides this, two minor peaks (tR =
3.9 and 6.6 min) with the same m/z and daughter ions were
observed. The compound with tR = 3.9 min was purified and
analyzed by NMR spectroscopy. The signals agree with the
data reported for the regioisomer of 8, iso-SDHCHC (iso-8 ;
Scheme 1).[9, 11]
Isochorismate (2) is both the physiological substrate of
MenD and a precursor of 4. The kinetic parameters of the puri-
fied MenD were determined for 4 : the catalytic efficiency
(kcat/Km) was found to be 6  10
3 times lower than for 2
(Scheme 1).[13] As expected, there is a competition for the
active site of MenD, and a peak corresponding to the physio-
logical product SEPHCHC (7, tR = 7.2 min, m/z 327.1) was also
observed. To increase the selectivity towards 4 versus 2 and to
broaden its specificity towards 5 as a substrate, MenD had to
be rationally optimized. MenD forms a dimer of dimers in solu-
tion. One dimer pair forms the active site, which consists
mainly of a hydrophobic pocket and a highly basic patch.[15]
Until now, efforts to obtain the EcMenD structure with bound
2 have been unsuccessful.[16] Clues as to the binding of sub-
strates derive from mutation studies using 2 and a substrate
analogue in combination with kinetic parameters.[15, 17, 18]
To modify the substrate scope of MenD, we proposed a
model for the binding of 2 that explains the outcome of the
reaction. Furthermore, the following criteria were taken into
account.
1) Intramolecular [3,3’]- and [1,5’]-sigmatropic rearrangements
of isochorismate should be avoided.[19, 20]
2) The distance of 2 to succinic semialdehyde-ThDP (formed
by enzymatic decarboxylation of 6) should be within the
van der Waals radius and smaller than 3.7 .[21]
3) The model should be in accordance with the experimental
data and kinetic parameters.
4) The binding of 2 to MenD might not differ from the bind-
ing of this substrate to enzymes other than MenD: The iso-
chorismate synthase EntC and isochorismatase PhzD have
been co-crystallized with 2 and served as a basis for the
docking of 2 to MenD.[19]
In first place, the docking of the substrate isochorismate “as
it is” did not yield a model according to the criteria stated
above. For this reason, and according to the catalytic mecha-
nism,[18, 22] we assumed that a transition state is formed by an
opening of the double bond of carbons C1 and C6 of 2. This
changes the hybridization of both carbons from sp2 to sp3,
with an influence on the structure of the ring system. Docking
studies with a transition-like conformation containing only one
double bond in the ring system (“1,6-dihydroisochorismate”)
led to a model that explains the regio- and stereoselective
reaction outcome with MenD (Figure 1). According to the pro-
posed model, the cyclohexene ring of “1,6-dihydroisochoris-
mate” lies above and parallel to the thiazole ring of ThDP. This
hydrophobic part of the substrate is located in a hydrophobic
Scheme 1. Modification of natural pathways from chorismate (1) in E. coli. The kinetic parameters of purified MenD with isochorismate (2)[14] and 2,3-trans-
CHD (4 ; this work) are shown in green.
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pocket interacting with Ile474, Leu478, and Phe475. By means
of the repulsion of the carboxyl moiety, this pocket could pre-
vent the sigmatropic rearrangement of 2 into isoprephen-
ate.[18, 19] Nucleophilic attack of the succinic semialdehyde-ThDP
intermediate at C6 of 2 is thus reasonable. An electrophilic
attack at C1 of 2 should also take place, to finalize the opening
of the C1=C6 double bond. A conserved water molecule that
lies between Ser32 and Gln118 could be responsible for this
step, in analogy to the mechanism demonstrated for EntC.[19]
In our model, the C1-carboxyl and C6-hydroxy groups of
“1,6-dihydroisochorismate” interact mainly with Arg107. Re-
garding the enolpyruvyl moiety, the side chain of Asn117 is sit-
uated next to the carboxylate and Leu478 accommodates the
methylene moiety (Figure 1 A). The substrate channel matches
exactly the shape of the enolpyruvyl moiety (Figure 1 B). A
further indication that Asn117 plays an important role in the
interaction with the enolpyruvyl moiety comes from the com-
parison with the crystal structure of Bacillus subtilis MenD
(BsMenD, Figure 1 C; PDB ID: 2X7J).[17a] The sequence identity
of EcMenD and BsMenD is low (28 %); Pro116 in BsMenD,
which defines the conformation of the loop, is located in the
position of Asn117 found for EcMenD. Nevertheless, in the
position of the lateral chain of EcMenD Asn117, lies the lateral
chain of BsMenD Asn431. It is therefore likely that this amide
group is a crucial factor for coordination of the enolpyruvyl
moiety of 2.
The previous docking models of EcMenD with 2 predicted
the same residues (Ile474, Leu478, Phe475) as interacting with
the unsubstituted ring edge; however, the reported orientation
of 2 was different.[15, 18] Arg107 and Arg33 are known to be im-
portant for the binding of 2 :[15, 18] mutation of these two moiet-
ies to lysine led to a smaller kcat with the analogue 2-succinyl-
5-carboxymethoxy-6-hydroxycyclohex-3-ene-1-carboxylate, rel-
ative to isochorismate (2).[18] As this analogue and 2 differ
solely in the enolpyruvyl moiety, it was suggested that Arg107
and Arg33 interact with this moiety.[18] However, as 2 has two
carboxylic acid moieties, it is difficult to unequivocally judge
which of the carboxylates binds to each Arg residue. Recently,
M. tuberculosis MenD (MtbMenD) was crystallized with bound
2.[23] Although EcMenD and MtbMenD share low sequence
identity (30 %), some residues that interact with 2 are con-
served and are positioned in a similar manner concerning this
substrate, namely Ile474, Leu478, Phe475, Arg107, and Gln118.
In particular, Arg107 was shown to bind the C1-carboxyl and
C6-hydroxy groups, and Gln118 the C6-hydroxy group,[23] as
predicted for EcMenD in our model.[24] Regarding the loop that
interacts with the enolpyruvyl moiety, in MtbMenD the side
chain of Arg282 is involved in a bidentate interaction, while
this residue is not conserved in EcMenD.
To produce 8 in vivo selectively, the active site of MenD
needed to be modified in such a way that the native substrate
2 is refused. According to the new binding model, residue
Arg107 coordinates structural elements that are common to 2
and 2,3-trans-CHD (4), namely the C1-carboxyl and C6-hydroxy
groups. A mutation of this residue is thus expected to affect
the activity in the same way for both substrates. To test this
hypothesis, Arg107 was mutated to the sterically demanding
tyrosine. The production of 7 and 8 was lowered 13-fold in
both cases, confirming our assumption (Figure 2).
As 2 and 4 differ exclusively in the enolpyruvyl moiety, the
mutations were focused in the region of the active site inter-
acting with this group. Firstly, Asn117 of MenD was predicted
to establish a hydrogen bond with the enolpyruvyl moiety of
the substrate. To maintain this bond with the C3-hydroxy
group of 4, the alternative residues Gln, Lys, Arg, Thr, and Asp
were selected. The variants Asn117Asp, Asn117Gln, and
Asn117Thr showed a similar 8/7 ratio compared to wild-type
MenD (about 2:1), while mutation of Asn117 to Lys and Arg
resulted in an increased 8/7 ratio to about 8:1 and 6:1, respec-
tively (Figure 2). The proportion of unconsumed 4 increased
for most variants, but was not significantly affected for
Asn117Gln and Asn117Arg.
Further, the moiety Leu478 was targeted. This residue is
located in a hydrophobic pocket, in which Ile474, Leu477, and
Figure 1. Docking model of EcMenD (PDB ID: 3HWX) with “1,6-dihydroiso-
chorismate” as a surrogate intermediate. A) View of the active center with
“1,6-dihydroisochorismate”. B) View of the substrate channel. C) Overlap of
the active sites of EcMenD and BsMenD (PDB ID: 2X7J).
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Phe475 form a loop (Figure 1 A), the flexibility of which could
be important for catalysis. In vitro studies with the variants
Leu478Glu and Leu478Lys showed a lower relative enzymatic
activity with 4 (43 and 80 %, respectively). The variant
Leu478Thr, which did not compromise the conversion of 4,
was expressed in E. coli and resulted in a higher 8/7 ratio (ca.
8:1). To confirm the results of the variant screenings, high-cell-
density fermentations were performed for the MenD single
variants Asn117Arg and Leu478Thr, as well as for the double
variant Asn117Arg–Leu478Thr (Figures 2 and S2). For the single
variants, the titer of SDHCHC (8 and iso-8) was in the range of
3.3–5.3 g L1, while for wild-type MenD it was 1.9 g L1. For the
double-variant MenD Asn117Arg-Leu478Thr, SDHCHC forma-
tion was lower than for the single variants ; nevertheless, the
8/7 ratio was the highest (>70-fold than that for the wild
type).
To further increase the chemical diversity, 2,3-trans-CHA (5)
was investigated as a substrate of MenD. In previous work, the
envisaged product 2-succinyl-6-amino-5-hydroxycyclohex-3-
ene-1-carboxylate (SAHCHC, 10 ; Scheme 1) was not found,[11]
possibly due to detection limits. To improve the sensitivity, we
established an LC-MS/MS method based on hydrophilic inter-
action chromatography (HILIC) to investigate the conversion of
5 into 10. The parent ion [SAHCHCH+] (m/z 255.9) was frag-
mented and the transition ions (m/z 255.9!133.0 and m/z
255.9!211.7) were used for the quantification by multiple re-
action monitoring scans. The detection limit was thus lowered
nearly 1000-fold relative to the previously employed NMR
method.[11] A concentration of 0.09 mm 10 (1.5 % conversion)
was quantified for the MenD-catalyzed enzymatic reaction of 5
with a-ketoglutarate (6) ; hence, (trace) activity with 5 as a sub-
strate has been detected for the first time.
Based on the docking model (Figure 1), we hypothesized
that Arg107 is the main impediment for the conversion of 5.
Arg107 lies next to the hydroxy moiety of 2. The side chain of
Arg, when positively charged, might repulse the amino moiety
of 5. The surface potential of the active site of MenD indicates
that the substrate channel is dominated by positive charges.
Previous studies have shown that the loop composed of
Arg107–Ala119 has a strong influence on the conversion of
2,3-trans-CHD (4 ; Figure 1);[24] in particular, the amino acid
Gln118, that lies at the end of the loop, is crucial for enzyme
activity. Thus, mutation of Gln118 of MenD to either Glu, His,
or Ala reduced the activity with 4.[24]
Our variations of Arg107 were therefore designed to mini-
mize the perturbation of this loop. To reduce the steric hin-
drance and remove the positive charge, Arg107 was ex-
changed for Glu, Lys, Ile, or Tyr. The variant Glu107 also fulfilled
the goal of introducing a negatively charged side chain that
could interact with the (putatively positively charged) amine of
5. The obtained variants were expressed and purified, and as-
sayed in vitro for the conversion of 4 and 5 (Figures 3 and S3).
The variants showed up to 23-fold conversion of 5 relative to
wild-type MenD; concomitantly, the conversion of 4 was low-
ered to 5–20 % relative activity.
With the same strategy as used for the in vivo conversion of
4, a 2,3-trans-CHA (5) overproducer strain was used for the ex-
pression of MenD. Following the approach used by Bongaerts
et al. ,[9] E. coli F68/pC35-2 was obtained by expressing two
genes (phzD-phzE) from Pseudomonas aeruginosa encoding
ADIC synthase, which forms 3 that is hydrolyzed by the iso-
chorismatase PhzD to 5 (Scheme 1).[25] Genes encoding wild-
type MenD and MenD Arg107Ile were cloned into this strain,
resulting in yields of 10 and 64 mg L1 SAHCHC (10), respec-
tively.
Analogously to iso-8, iso-SAHCHC (iso-10), was purified and
its structure elucidated by NMR spectroscopy. In accordance to
the data obtained for the regioisomer iso-8, a methylene
group was identified in the ring. The cross-coupling between
the two multiplet signals at 2.30–2.40 and 2.65–2.70 ppm to
the C4 carbon (HSQC), proved the presence of two diastereo-
topic protons. Again, the three-bond coupling between H3
Figure 2. Fermentation profile of MenD variants for the conversion of 4. For
each variant, 100 % corresponds to the molar sum of unconsumed 4, and
the products 7 and 8/iso-8.
Figure 3. In vitro activity of MenD variants with 2,3-trans-CHD (4) and 2,3-
trans-CHA (5) as the substrates, and SAHCHC (10 and iso-10) production in
high-cell-density fermentations.
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and C1’ (HMBC) provided proof of the occurrence of an a,b-
unsaturated carbonyl in iso-10 (Scheme 1).
The shikimate pathway provides access to primary and sec-
ondary metabolites, several of them in use as pharmaceuticals
or herbicides.[6] The diversity of metabolites is rooted in the
multifunctional reactivity of chorismate (1) and isochorismate
(2), as well as in the diversity and the promiscuity of enzymes
acting on these two regioisomers. Several new (natural) enzy-
matic transformations of 1 or 2 have been recently added to
the previously known biosynthetic branches of the shikimate
pathway.[4, 26] We aimed at inserting “unnatural” new products
into the plethora of possible enzymatic products by rational
variation of enzymatic activity towards new substrates, them-
selves produced by metabolic engineering. Starting from an
enhanced shikimate pathway and making use of the (natural
and tailored) promiscuity of MenD, the highly functionalized
compounds SDHCHC (8) and SAHCHC (10), and the regio-
isomers iso-8 and iso-10, were made accessible in vitro and in
vivo.
The trace activity observed for wild-type MenD with one of
the newly accomplished substrates (5, 1.5 % conversion) sug-
gests that similar traits might exist in nature. Moreover, the
rationally designed variation Arg107Lys (position 102 according
to the standard numbering scheme of thiamine diphosphate
dependent decarboxylases[27]) can be found in enzyme candi-
dates from different bacteria, although at a very low abun-
dance (0.3 % of all MenD homologues in contrast to more than
94.0 % having Arg102). Based on pairwise sequence identities
of those MenD homologues that contain residues other than
arginine at standard position 102, a protein sequence network
was formed (Figure 4 and the Supporting Information).
One community of this network predominantly contained
sequences with Gln and individual sequences with Lys, Ile, or
Tyr among other variants (Supporting Information). It is tempt-
ing to assume that several variants of MenD homologues with
yet unexplored substrate scope already occur in nature, includ-
ing the mutations at Arg102 assessed in the present study. The
possible biochemical peculiarities of the strains encoding these
MenD homologues might be a promising starting point for the
identification of uncommon MenD-catalyzed reactions. Al-
though 5 might be too stable to represent a general branching
point,[29] highly reactive ADIC (3) and aminodeoxychorismate
might well be. Accordingly, we propose that the chorismate-
isochorismate “tree” possesses as yet unexplored branches and
its “fruits”, the secondary metabolites, are even more diverse
than previously suspected.
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olites : The route to menaquinone has
been modified and the substrate range
of the enzyme MenD tailored for the
synthesis of nonphysiological com-
pounds. The results demonstrate that a
few mutations are sufficient to modify
substrate recognition by MenD, hence
raising the question of the occurrence
of these or similar, but so far unknown,
transformations in nature.
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